ImportRefusal LogoImportRefusal

Violation Code: 3340

FDA Violation

Charge Code: DE/RX KIT

79
Total Refusals
36
Affected Firms
2/24/2022
Latest Case
3/1/2007
First Case

Violation Details

Violation Code (ASC ID)
3340
Charge Code
DE/RX KIT
Description
The article appears to be a combination medical device/prescription drug kit for which the prescription drug component was manufactured in the U.S., is offered for import by other than the manufacturer, and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
Legal Section
801(d)(1),(2); IMPORTATION RESTRICTED

Most Affected Firms

#Firm NameLocationCases
1Bard Reynosa S.A. De C.V.Reynosa, MEXICO14
2Edwards Lifesciences AgRio Haina, DOMINICAN 8
3Tri State De MexicoMexicali, MEXICO6
4P KrishnamurthyBangalore, INDIA5
5ICU Medical, Inc.Lake Forest, UNITED STA4
6Medique ProductsFort Myers, UNITED STA3
7Becton Dickinson & CompanyFranklin Lakes, UNITED STA3
8Medline Industries, LPMundelein, UNITED STA2
9CovidienTijuana, MEXICO2
10DMS Holdings, Inc. dba HealthSmartWaukegan, UNITED STA2
11Jml Direct America LlcLondon, UNITED KIN2
12DSHealthcare Inc. dba Sultan Health CareHackensack, UNITED STA2
13MERK MEXICO SANAUCULPCIN, MEXICO2
14International Medication Systems Ltd.South El Monte, UNITED STA2
15Hospira, Inc.Lake Forest, UNITED STA1
16Carnot LaboratoriosMexico, MEXICO1
17Terzo SandroRoma, ITALY1
18Vista PharmBirmingham, UNITED STA1
19Sanofi-Aventis De MexicoOcoyoacac, MEXICO1
20Genesis II Church of Health and HealingUnknown, IRELAND1

Recent Import Refusals

DateProductFirm
2/24/2022
LISINOPRIL (ANTI-HYPERTENSIVE)
62CDB65
4/21/2021
ANTI-ANEMIC, N.E.C.
61CDA99
4/21/2021
DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
62GDA18
4/21/2021
ANTI-ANEMIC, N.E.C.
61CDA99
4/21/2021
ANTI-ANEMIC, N.E.C.
61CDA99
4/21/2021
CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
61XDA14
4/12/2021
ETHYL ALCOHOL (ANTI-MICROBIAL)
62HAL05
8/26/2020
HYDROCODONE BITARTRATE (ANTI-TUSSIVE/COLD)
62UBY13
9/10/2018
LIDOCAINE
60QCP07
Hospira, Inc.UNITED STA
2/12/2016
ESTROGEN N.E.C.
64GCD99
2/5/2016
HEARING AID, AIR CONDUCTION WITH WIRELESS TECHNOLOGY
77OSM
2/5/2016
HEARING AID, AIR CONDUCTION WITH WIRELESS TECHNOLOGY
77OSM
10/1/2015
INTRODUCER, SYRINGE NEEDLE
80KZH
10/1/2015
SYRINGE, ANTISTICK
80MEG
10/1/2015
SYRINGE, ANTISTICK
80MEG

Related Violations

Other violations under the same legal section: 801(d)(1),(2); IMPORTATION RESTRICTED

CodeCharge CodeCases
179AGR RX1895
3875708REIMPRT6

Frequently Asked Questions

What is FDA violation code 3340?

3340 is an FDA violation code that indicates: "The article appears to be a combination medical device/prescription drug kit for which the prescription drug component was manufactured in the U.S., is offered for import by other than the manufacturer, and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.". This violation is based on 801(d)(1),(2); IMPORTATION RESTRICTED of the Federal Food, Drug, and Cosmetic Act.

How many import refusals have been issued for violation 3340?

According to FDA Import Refusal data, there have been 79 import refusals issued for violation code 3340, affecting 36 unique firms.

When was the most recent refusal for violation 3340?

The most recent import refusal for violation 3340 was on February 24, 2022.

What products are commonly refused for violation 3340?

Products commonly refused under violation 3340 include: LISINOPRIL (ANTI-HYPERTENSIVE), ANTI-ANEMIC, N.E.C., DICLOFENAC SODIUM (ANTI-INFLAMMATORY). These products were refused entry because they did not meet FDA requirements.

What is the legal basis for FDA violation code 3340?

Violation code 3340 is based on 801(d)(1),(2); IMPORTATION RESTRICTED of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This section of the law establishes requirements that imported products must meet to be allowed entry into the United States.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.